Treatment Related Risk Factors for Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement in Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

被引：0
|
作者：
No, H. J. [1 ]
Tam, M. M. [2 ]
Wu, P. [3 ]
机构：
[1] Flushing Hosp Med Ctr, Flushing, NY USA
[2] NYU Langone Hlth, Dept Radiat Oncol, New York, NY USA
[3] Holy Name Med Ctr, Teaneck, NJ USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 106卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
386
引用
收藏
页码：1214 / 1214
页数：1
相关论文
共 50 条
  • [21] Phase 3 study of Pembrolizumab plus Chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC): KEYNOTE-412
    Machiels, Jean-Pascal
    Yen, Chia-Jui
    Licitra, Lisa
    Rischin, Danny
    Waldron, John
    Burtness, Barbara
    Gregoire, Vincent
    Agarwala, Sanjiv
    Tao, Yun Gan
    Yorio, Jeffrey
    Aksoy, Sercan
    Ikeda, Sadakatsu
    Hong, Ruey-Long
    Ge, Joy Yang
    Brown, Holly
    Bidadi, Behzad
    Siu, Lillian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [22] eVOLVE-HNSCC: A global phase 3 study of volrustomig as sequential therapy for unresected locally advanced head and neck squamous cell carcinoma (LA-HNSCC) following definitive concurrent chemoradiotherapy (cCRT)
    Haddad, Robert I.
    Ruscica, Dario
    Visa, Alexandra
    Li, Xia
    Licitra, Lisa F.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Concurrent Weekly Cisplatin and Simultaneous Integrated Boost-Intensity Modulated Radiotherapy (SIB-IMRT) in Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
    Ahmed, Imtiaz
    Krishnamurthy, Sapna
    Bhise, Rohan
    Vinchurkar, Kumar
    Kalloli, Mahesh
    ORAL ONCOLOGY, 2021, 118
  • [24] Enteral nutrition during the treatment of head and neck carcinoma -: Is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?
    Mekhail, TM
    Adelstein, DJ
    Rybicki, LA
    Larto, MA
    Saxton, JP
    Lavertu, P
    CANCER, 2001, 91 (09) : 1785 - 1790
  • [25] Targeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)
    Jose Echarri, Maria
    Lopez-Martin, Ana
    Hitt, Ricardo
    CANCERS, 2016, 8 (03)
  • [26] PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (PEG) PLACEMENT FOR NUTRITIONAL SUPPORT OF SQUAMOUS CARCINOMAS OF THE HEAD, NECK, AND ESOPHAGUS DURING CANCER-THERAPY
    MAMEL, JJ
    JONES, J
    BOYCE, HW
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1988, 83 (09): : 1022 - 1022
  • [27] Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)'
    Hanemaaijer, S. H.
    Kok, I. C.
    Fehrmann, R. S. N.
    van der Vegt, B.
    Gietema, J. A.
    Plaat, B. E. C.
    Vugt, M. A. T. M.
    Vergeer, M. R.
    Voortman, J.
    Leemans, C. R.
    Buter, J.
    Langendijk, J. A.
    Oosting, S. F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [28] Postoperative Combined Modality Treatment in High Risk Resected Locally Advanced Squamous Cell Carcinomas of the Head and Neck (HNSCC)
    Kirtane, Kedar
    Rodriguez, Cristina P.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [29] Correlation of deviation from intended cisplatin (CDDP) dose intensity with outcome in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) receiving concurrent chemoradiation (CRT)
    Liu, C. S.
    Elser, C.
    Huang, S.
    Pond, G. R.
    O'Sullivan, B.
    Chen, E. X.
    Waldron, J. N.
    Goldstein, D.
    Siu, L. L.
    Kim, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 "PembroRad" randomized trial
    Bourhis, J.
    Sire, C.
    Tao, Y.
    Martin, L.
    Alfonsi, M.
    Prevost, J. B.
    Rives, M.
    Lafond, C.
    Tourani, J. M.
    Biau, J.
    Geoffrois, L.
    Coutte, A.
    Liem, X.
    Vauleon, E.
    Drouet, F.
    Pechery, A.
    Guigay, J.
    Wanneveich, M.
    Auperin, A.
    Sun, X.
    ANNALS OF ONCOLOGY, 2020, 31 : S1168 - S1168
12345